Skip to content

Point-of-care test improves infant HIV diagnosis rate, treatment starts and retention in care

Ilesh Jani at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment

Paul Sax at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

A benign circle: how a combination of factors has reduced HIV infections in one of the hardest-hit parts of Africa

Mary Grabowski at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Men from Latin America and central Europe now outnumber sub-Saharan Africans in HIV diagnoses in European migrants

Across western Europe, migrants from all parts of the world start HIV treatment later

Living with diagnosed HIV infection for a long time is associated with poor quality of life

NAM endorses Undetectable equals Untransmittable (U=U) consensus statement

NAM endorses Undetectable equals Untransmittable (U=U) consensus statement

Sustained reductions in sexual risk behaviour following couples’ HIV testing

Delays in linkage to care after HIV diagnosis pose the biggest barrier to treatment access